Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Jaques Medioni"'
Autor:
Jean-Pierre Droz, Rolf Kaiser, Michael Merger, Christine Chevreau, Helene De Mont-Serrat, Jaques Medioni, Stéphane Oudard, Peter Stopfer
Publikováno v:
Anti-Cancer Drugs. 25:1081-1088
This open-label, phase II trial assessed the efficacy and safety of two doses of nintedanib, a triple angiokinase inhibitor targeting vascular endothelial growth factor, fibroblast growth factor, and platelet-derived growth factor signaling, in patie